Skin Microbiome Science Shapes the Next Generation of Microbiome-Friendly Cosmetics

Why it matters: The skin is home to millions of microbes that feed on sebum, sweat and skin proteins and, in return, help maintain the barrier, the acidic surface (acid mantle), antimicrobial peptide (AMP) production and immune education. Disruption of this ecosystem, called dysbiosis, is linked to dryness, high transepidermal water loss, premature ageing and inflammatory skin diseases. As consumers and the cosmetics industry move from an aseptic mindset to one of preserving resident microbes, understanding how products affect the microbiome has become important.

What was reviewed: This is a narrative review rather than a primary study. It describes how microbial communities differ across moist, sebaceous and dry skin sites. It explains the physical, chemical and immunological contributions of the microbiome to barrier function. It then covers dysbiosis in dandruff, acne, atopic dermatitis and ageing, and the effects of cosmetic ingredient classes (surfactants, lipophilic compounds, preservatives, fragrances, vitamins, UV filters). Finally, it surveys prebiotic, probiotic and postbiotic strategies. The text available for analysis was truncated, so later sections on specific ingredient classes and the end of the postbiotic table were not fully available.

Key results: Dandruff studies show higher S. epidermidis and Malassezia restricta with lower C. acnes, showing that even usually beneficial species can shift roles. In atopic dermatitis, S. aureus dominates and AMP expression is reduced, whereas S. epidermidis is more abundant in healthy skin. Ageing skin has fewer lipids and shows more diverse, potentially harmful colonization. On the cosmetic side, soap surfactants can alter stratum corneum lipids and persist on skin, neutral or alkaline rinse-off products shift pH away from the physiological 5.4–5.9, and methylparaben at 0.5–1.5% strongly inhibited S. epidermidis and C. acnes within 4–8 hours in vitro. However, real-use dilution (5–10 fold) and microbiome resilience may lessen the impact in practice. Prebiotic examples include fructo- and galactooligosaccharides, blackcurrant extract and plant polysaccharides, which favoured S. epidermidis over S. aureus in vitro. Small clinical studies (n = 12–74) reported increased diversity or shifts in bacterial abundance, with some improvement in hydration, TEWL or redness.

Implications: Microbiome-friendly formulation means minimizing ingredients that harm commensals (harsh surfactants, non-selective preservatives, unsuitable pH) and, where appropriate, adding prebiotics or postbiotics. Postbiotics offer longer shelf life, tolerance of pH and temperature, and no live cells, making them easier to formulate than probiotics. Probiotics face challenges including survival in semi-solid products, contamination risk, storage needs and microbial limits such as 1000 CFU/g in FDA guidance.

Caveats: Much evidence comes from in vitro or ex vivo tests and small, short clinical studies, often with industry-linked claims. Changes in diversity do not necessarily equal clinical benefit, and standards for defining microbiome-friendly are lacking. The authors stress the need for more research on ingredient-microbiome dynamics.